Search

everythinglearnresearchcommunity

for

Search:↓

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Polynucleotide gel injections help reduce hair loss and increase hair thickness in people with pattern hair loss, with few side effects.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Corticosteroids regrow hair better and faster than pentoxifylline for alopecia areata.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Ritlecitinib is safe and may effectively treat alopecia areata.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

High-dose steroid pulse therapy effectively regrows hair in severe multifocal alopecia areata.

A new hydrogel treatment reduces inflammation and promotes hair growth in alopecia areata.

A new hydrogel treatment reduces inflammation and promotes hair growth in alopecia areata.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

Candida antigen is an effective and promising treatment for alopecia areata.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Immunological treatment improved both neuropathy and alopecia.